close
NEW: LANDSCAPE IN GENE THERAPY COMPANIES
Analyses

NEW: LANDSCAPE IN GENE THERAPY COMPANIES

Gene Therapy is a rapidly and obviously evolving field that is now definitively recognized as a well-acknowledged major medical and scientific area. BioPharmAnalyses is proud to announce the launch of its new global commercial report “Landscape in Gene Therapy Companies“. This is the first such report that provides you with an actually updated information and an accurate international mapping in the dynamic and growing business of Gene Therapy Companies.

All the data presented have been collected and deeply analysed by skilled experts with more than 20 years of recognized experience in the competitive field of biotech and pharma industries.

In this 500-pages report, a must-have read one, you will  find included:

-More than 180 closely scrutinized companies

-More than 200 VC or investors mentionned

-More than 200 pathologies referred

– More than 200 clinical trials identified

– More than 500 products detected

This report provides you with an in-depth overview of companies involved in:

AAV-based Gene Therapy
LV-based Gene Therapy
RNA-based derived drugs, RNAi, mRNA Therapeutics
CDMO (Contract, Development and Manufacturing Organization)
-Miscellaneous (including Hubs and Non Viral Gene Transfer)

Each Technical Datasheet includes for every company:

General informations
(location, website, FTE, management with e-mail contacts)
Core business in Gene Therapy
Financial data (updated MAY 2018)
(stock informations, market cap, financial highlights, recent fundings, including main investors)
Pipeline (updated MAY 2018)
(discovery, pre-clinical, phase I / II / III, marketed products)
Orphan drug designations (updated MAY 2018)
Clinical trials (updated MAY 2018)
Latest developments in gene therapy (updated MAY 2018)
Latest publications and results (updated MAY 2018)

To get a sample (Reportsample).

To get the full report (Landscapesubscriptionform)

Published: 2018/05/27


COMMENTS ARE OFF THIS POST